Literature DB >> 3862745

Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.

R S Accolla, L Scarpellino, G Carra, J Guardiola.   

Abstract

Raji, a human B lymphoma line, expresses high levels of major histocompatibility complex (MHC) class II antigens. Conversely, none of the detectable human Ia antigens is present in RJ 2.2.5, an immunoselected Raji variant. Clonal analysis, biochemical characterization, and nucleic acid hybridization studies of hybrids between mouse spleen cells and RJ 2.2.5 show that MHC class II gene expression is regulated in trans by a factor which, as judged by dominance studies, has the characteristics of an activator. Such a positive trans acting factor is expressed in mouse spleen cells, and is able to implement MHC class II gene expression across species boundaries. Expression of this factor in spleen cells strongly suggests that it plays a role in in vivo regulation of Ia expression. Additional data suggest that different subsets of class II genes such as DR and DQ may, in part, be regulated by different mechanisms. It has also been possible to show that the amount of In chain-specific mRNA, present at reduced levels in RJ 2.2.5 cells compared to the parental Raji cells, drastically increased in human X mouse cells hybrids reexpressing human Ia antigens, suggesting that the In chain gene and the class II genes, although located on different chromosomes, are regulated in a concerted fashion, either directly through the same implementing factor, or indirectly through a cascade mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3862745      PMCID: PMC2187858          DOI: 10.1084/jem.162.4.1117

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells.

Authors:  R S Accolla; G Carra; F Buchegger; S Carrel; J P Mach
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

2.  Transcriptional regulation of HLA class II and invariant chain genes.

Authors:  F Levine; H A Erlich; B Mach; D Pious
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

Review 3.  The human Ia system: an overview.

Authors:  R S Accolla; A Moretta; S Carrel
Journal:  Semin Hematol       Date:  1984-10       Impact factor: 3.851

4.  Nomenclature for factors of the HLA system 1984.

Authors:  W F Bodmer; E Albert; J G Bodmer; J Dausset; F Kissmeyer-Nielsen; W Mayr; R Payne; J J van Rood; Z Trnka; R L Walford
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Linkage map of two HLA-SB beta and two HLA-SB alpha-related genes: an intron in one of the SB beta genes contains a processed pseudogene.

Authors:  J Trowsdale; A Kelly; J Lee; S Carson; P Austin; P Travers
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

7.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

8.  Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon.

Authors:  F Rosa; D Hatat; A Abadie; D Wallach; M Revel; M Fellous
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Molecular localization of human class II MT2 and MT3 determinants.

Authors:  C K Hurley; R C Giles; G Nunez; R DeMars; L Nadler; R Winchester; P Stastny; J D Capra
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 17.579

10.  Interleukin-induced increase in Ia expression by normal mouse B cells.

Authors:  N W Roehm; H J Leibson; A Zlotnik; J Kappler; P Marrack; J C Cambier
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  36 in total

1.  HLA-DR peptide occupancy can be regulated with a wide variety of small molecules.

Authors:  Francesca Blazekovic; Dana Odukoya; Shanitra N Butler; James A Mauro; Michael Ramsamooj; Erika Puleo; Karoly Szekeres; Dibyendu Dana; Sanjai Kumar; Govind Ragupathi; George Blanck
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

Authors:  C Cambiaggi; M T Scupoli; T Cestari; F Gerosa; G Carra; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.

Authors:  R S Accolla; P Dellabona; L Scarpellino; G Carra; S Sartoris
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter.

Authors:  M N Ombra; G Del Pozzo; C Perfetto; A Maffei; J Guardiola
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 5.  Control of transcription at the murine A alpha locus.

Authors:  M Boothby; H C Liou; P W Finn; E Gravallese; L H Glimcher
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 6.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

7.  Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

9.  Recognition of distinct HLA-DQA1 promoter elements by a single nuclear factor containing Jun and Fos or antigenically related proteins.

Authors:  M Neve Ombra; M Autiero; A DeLerma Barbaro; R Barretta; G Del Pozzo; J Guardiola
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

Review 10.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.